113 related articles for article (PubMed ID: 3862902)
1. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.
Matthews TJ; Weinhold KJ; Langlois AJ; Bolognesi DP
J Natl Cancer Inst; 1985 Oct; 75(4):703-8. PubMed ID: 3862902
[TBL] [Abstract][Full Text] [Related]
2. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
Weinhold KJ; Bolognesi DP; Matthews TJ
J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
[TBL] [Abstract][Full Text] [Related]
3. Immunologic control of a retrovirus-associated murine adenocarcinoma. VII. Tumor cell destruction by macrophages and IgG2A.
Langlois AJ; Matthews TJ; Weinhold KJ; Bolognesi DP
J Natl Cancer Inst; 1985 Oct; 75(4):709-15. PubMed ID: 3862903
[TBL] [Abstract][Full Text] [Related]
4. Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.
Langlois AJ; Matthews T; Roloson GJ; Thiel HJ; Collins JJ; Bolognesi DP
J Immunol; 1981 Jun; 126(6):2337-41. PubMed ID: 7229378
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity.
Bast RC; Knapp RC; Mitchell AK; Thurston JG; Tucker RW; Schlossman SF
J Immunol; 1979 Nov; 123(5):1945-51. PubMed ID: 489967
[TBL] [Abstract][Full Text] [Related]
7. Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.
Matthews TJ; Collins JJ; Roloson GJ; Thiel HJ; Bolognesi DP
J Immunol; 1981 Jun; 126(6):2332-6. PubMed ID: 7229377
[TBL] [Abstract][Full Text] [Related]
8. Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for Fc receptor-dependent cellular cytotoxicity and phagocytosis. Relationship to endogenous C1q availability.
Leu RW; Zhou AQ; Rummage JA; Kennedy MJ; Shannon BJ
J Immunol; 1989 Nov; 143(10):3250-7. PubMed ID: 2809201
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
[TBL] [Abstract][Full Text] [Related]
10. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
11. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
Steplewski Z; Lubeck MD; Scholz D; Loibner H; McDonald Smith J; Koprowski H
In Vivo; 1991; 5(2):79-83. PubMed ID: 1768791
[TBL] [Abstract][Full Text] [Related]
13. Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity.
Lichtenstein AK; Kahle J; Berek J; Zighelboim J
J Immunol; 1984 Jul; 133(1):519-26. PubMed ID: 6373934
[TBL] [Abstract][Full Text] [Related]
14. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
15. Influence of antibody isotype on passive serotherapy of lymphoma.
Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
[TBL] [Abstract][Full Text] [Related]
16. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
Tomazic V; Ehrke MJ; Mihich E
Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
[TBL] [Abstract][Full Text] [Related]
18. Thioglycollate-elicited mouse peritoneal macrophages are less efficient than resident macrophages in antibody-dependent cell-mediated cytolysis.
Shaw DR; Griffin FM
J Immunol; 1982 Jan; 128(1):433-40. PubMed ID: 7054283
[TBL] [Abstract][Full Text] [Related]
19. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
20. Influence of acetylsalicylic acid on antibody-dependent cellular cytotoxicity (ADCC) of peritoneal macrophages.
Lötzerich H; Jäpel M; Rogalla K
Anticancer Res; 1993; 13(1):87-91. PubMed ID: 8476231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]